Hints and tips:
Showing results for Takeda Pharmaceuticals U.S.A, Inc. (f/k/a Takeda Pharmaceuticals North America, Inc.)
...The latest acquisition contributes to a record year for Japanese outbound deals, led by Takeda Pharmaceutical’s £46bn agreement to buy Irish drugmaker Shire in April....
...Others focused on the significance of Takeda’s move for its country’s pharmaceuticals industry....
...The European gas market was “stable”, Taiyo said, noting it was second in size only to North America....
...Corporate giants including US cable group Comcast, wireless provider T-Mobile and Japan’s pharmaceutical maker Takeda reached for M&A to head off competitive threats and expand their businesses....
...The conglomerate’s most recent 13-F filing revealed a new stake in Israeli drugmaker Teva Pharmaceuticals and an increased Apple stake, while its position in IBM was sharply reduced....
...Separately, Hikma disclosed on Thursday that it will expand its licensing and distribution pact with Japan’s Takeda Pharmaceuticals that will add new products to its Middle East and North Africa portfolio...
...maker Patheon, and Takeda’s $5.4bn takeover of cancer specialist Ariad....
...Japanese prescription drug maker Astellas Pharma, a company that derives a third of its revenue from North America, according to Bloomberg data, tumbled 3.9 per cent....
...The S&P 500 index was off by 0.1 per cent, reversing a rise of as much as 0.3 per cent....
...This has left the company’s share price almost unchanged over the period while the S&P pharmaceuticals index has doubled....
...The investment came a day after AstraZeneca agreed to pay Takeda of Japan $575m for a portfolio of respiratory medicines and a month after it bought ZS Pharma, a US biotech company, for $2.7bn....
...But by Thursday the company was forced into an embarrassing retraction, with Michael O’Leary apologising and saying Ryanair had “f****** up”....
...Cash-rich Japanese drugmakers have been on a spending spree ahead of the so-called “patent cliff”, highlighted by Takeda Pharmaceutical’s $13.7bn purchase of Nycomed, the Swiss drugmaker, in 2011....
...Takeda, for example, has led the Japanese charge for large deals in recent years with its $20bn acquisition of Swiss drugmaker Nycomed in 2011 and Millennium Pharmaceuticals, a US biotech company, in 2008...
...But pharmaceutical leaders need to take a hard look at themselves....
...(Bloomberg) GM “must turn over documents related to its subprime auto-lending under a subpoena issued by the U.S....
...(Reuters) “International banks are looking to put together a group of investors to buy disputed Argentine debt and resolve a U.S. lawsuit that is blocking the country from servicing any of its foreign bonds...
...(Financial Times) “A U.S. jury ordered Takeda Pharmaceutical Co Ltd to pay $6 billion in punitive damages and Eli Lilly and Co to pay $3 billion in a case claiming that cancer risks to the diabetes drug...
...(Financial Times) China labels iPhone a security threat: China’s influential state broadcaster on Friday called a location-tracking function offered by Apple Inc.’s iPhone a “national security concern,”...
...(Reuters) “Exelon, the largest U.S. nuclear operator, has agreed to buy Pepco Holdings Inc. for more than $5.4 billion in cash, according to people familiar with the transaction.”...
...Generic drug makers Teva and Sun Pharma will pay $2.15bn to Pfizer and Takeda to settle a long-running patent dispute in the US over Protonoix, a stomach acid treatment....
...Takeda of Japan last year acquired Nycomed, bringing it a substantial portfolio of medicines in emerging markets led by Russia. Additional reporting by Andrew Jack in London...
...(Reuters) “A federal court in New York has ordered MF Global Inc. to pay $1.2 billion in restitution to the failed brokerage firm’s customers, the U.S....
...and munitions to as many as 50 sites to make them harder for the U.S. to track, according to American and Middle Eastern officials.” http://on.wsj.com/1ep4FW3 First domestic pharmaceutical group caught...
...(Financial Times) (NYT) “A U.S. regulator filed lawsuits against Morgan Stanley and eight other banks over the sale of nearly $2.4 billion in mortgage-backed securities to two credit unions that later failed...
International Edition